FDA approves new, cheaper rival to EpiPen allergy shot
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical greed.
FDA: Avoid fake 'miracle' cancer treatments sold on internet
U.S. regulators are warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat or prevent cancer.